← 產業報告目錄

Collagen and Hyaluronic Acid Intra-Articular Injections Market by Product Type [Hyaluronic Acid Injection (Single Injection, Multiple Injection), Collagen Injection, Combination of Hyaluronic Acid and Collagen], by Application (Knee Osteoarthritis, Joint Pains, Veterinary Applications, Post-Operative Recovery, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) Forecast till 2035

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2025-07-16頁數 184報告編號 MRFRHC57883CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Collagen and Hyaluronic Acid Intra-Articular Injections Market by Product Type [Hyaluronic Acid Injection (Single Injection, Multiple Injection), Collagen Injection, Combination of Hyaluronic Acid and Collagen], by Application (Knee Osteoarthritis, Joint Pains, Veterinary Applications, Post-Operative Recovery, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) Forecast till 2035 Market Overview The global collagen and hyaluronic acid intra-articular injections market is anticipated to grow at a CAGR of 6.15% during the forecast period to attain the value of USD 6,324.80 million by 2035. Collagen and hyaluronic acid intra-articular injections are minimally invasive procedures that relieve joint disorders such as osteoarthritis. By directly injecting natural substances into the joint space, these injections allow for better joint lubrication, less irritation, and increased support to cartilage. Consequently, they alleviate discomfort, increase joint function, and postpone the moment when surgical solutions are required. The increasing prevalence of osteoarthritis worldwide, among other joint diseases, is the major factor, which led collagen and hyaluronic acid intra-articular injections to the biggest market growth. The number of people suffering from osteoarthritis is estimated to exceed 130 million by the year 2050. Consequently, the need for effective and minimally invasive therapies is rising. These injections not only facilitate the patient in getting rid of the pain but also help in the restoration of the lost mobility, and in addition, they also reduce the patient's dependence on surgical methods, which makes them absolutely necessary in today's orthopedic care. Key Company Development In May 2021, Seikagaku Corporation, in collaboration with Ono Pharmaceutical, celebrated a major product innovation with the arrival of JOYCLU 30mg Intra-articular Injection in Japan. JOYCLU is the first hyaluronic acid-diclofenac conjugate using the company's proprietary technology, which offers both lubrication and anti-inflammation in one single formulation. It was created to be a new and functionally improved joint agent that could give a solution, a light but nevertheless effective one, to the countless patients who suffer from osteoarthritis. The company Seikagaku, which is a few months later, in August 2021, deepens its dedication to this field by introducing HyLink, a single-injection viscosupplement for knee osteoarthritis. This step of Seikagaku to address the unmet needs in the field of joint health is remarkable. This product underlines Seikagaku’s strategy of going for the least invasive solutions and the company’s goal to make patient adherence easier, reduce the treatment burden, and achieve durable clinical outcomes in orthopedic care. Major Players Key players in the global collagen and hyaluronic acid intra-articular injection market are Seikagaku Corporation, Bioventus, Inc., Anika Therapeutics, Inc., Zimmer Biomet, Sanofi, Fidia Farmaceutici S.p.A., Teva Pharmaceutical Industries Ltd., Ferring B.V., Dr. Reddy's Laboratories Ltd., Semical Biosurgery, Avanos Medical, Inc., and Maxigen Biotech Inc. (MBI). Report Attribute Details Market Size 2024 USD 3,046.46 Million Market Size 2035 USD 6,324.80 Million CAGR (2025-2035) 6.15% Base Year 2024 Market Forecast Period 2025-2035 Historical Data 2019-2024 Market Segmentation Insights By Product Type: Hyaluronic acid Injection - 6.34%, Collagen Injection - 5.45%. By Application: Knee Osteoarthritis – 6.52%, Joint Pains – 5.74%. By Distribution Channel: Hospital Pharmacies – 6.37%, Retail Pharmacies – 5.36%. Regional Insights The North American market is still very strong, mainly supported by a plentiful number of osteoarthritis patients and demand for minimally invasive joint treatments. The United States leads the collagen and hyaluronic acid intra-articular injections market with a value of USD 1,211.26 million, while Canada follows as the second-largest contributor at USD 170.35 million. The front-running pharmaceutical companies are extensively investing in the clinical trials that are the engines of innovation and market expansion. Europe is a good example of stability, with the repeated use of local injections in the most significant healthcare markets of the continent. Germany dominates the collagen and hyaluronic acid intra-articular injections market with USD 130.61 million, followed by the UK at USD 94.89 million and France at USD 83.34 million, making them the region’s leading contributors. Positive patient reimbursement and vigorous physician support are the main factors for a gradual increase. The Asia-Pacific region is a rapidly growing market, with the fastest expansion rate, and is supported by healthcare modernization and the aging population trend. China leads the collagen and hyaluronic acid intra-articular injections market at USD 127.42 million, while India follows as the second-largest contributor with USD 83.96 million. The region's market is also helped by the rise of affordability and the spread of awareness in Southeast Asia. Latin America shows moderate but growing adoption, with Brazil and Argentina driving demand. Private healthcare networks play a critical role in expanding access to advanced intra-articular therapies. However, cost pressures and dependency on imported products remain significant barriers. The Middle East & Africa region reflects a mixed landscape, with rapid adoption in developed Gulf economies and slower uptake in sub-Saharan Africa. Rising incidences of lifestyle-driven joint disorders create future potential for growth. Continued healthcare investments and international partnerships are gradually improving access across the region.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ........... 21 1.1 OVERVIEW .... 21 1.2 MARKET ATTRACTIVENESS ANALYSIS ....... 22 1.3 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE ....... 23 1.4 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION .......... 24 1.5 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL ....... 25 1.6 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION ... 26 2. MARKET INTRODUCTION ........ 28 2.1 DEFINITION ............ 28 2.2 SCOPE OF THE STUDY ............ 28 2.3 RESEARCH OBJECTIVE .......... 28 2.4 MARKET STRUCTURE ............ 28 3. RESEARCH METHODOLOGY ............ 29 3.1 OVERVIEW .... 29 3.2 DATA FLOW ............ 31 3.2.1 DATA MINING PROCESS ..... 31 3.3 PURCHASED DATABASE: ....... 32 3.4 SECONDARY SOURCES: .......... 33 3.4.1 SECONDARY RESEARCH DATA FLOW: .......... 34 3.5 PRIMARY RESEARCH: ... 35 3.5.1 PRIMARY RESEARCH DATA FLOW: ............ 36 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ........ 37 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ......... 37 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........... 38 3.6.1 REVENUE ANALYSIS APPROACH .... 38 3.7 DATA FORECASTING..... 39 3.7.1 DATA FORECASTING TYPE ... 39 3.8 DATA MODELING ............ 40 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........ 40 3.8.2 DATA MODELING: ... 41 3.9 TEAMS AND ANALYST CONTRIBUTION ....... 43 4. MARKET DYNAMICS ...... 45 4.1 INTRODUCTION ..... 45 4.2 DRIVERS ......... 46 4.2.1 RISING PREVALENCE OF OSTEOARTHRITIS AND JOINT DISORDERS .... 46 4.2.2 GROWING AGING POPULATION ....... 46 4.3 RESTRAINTS .......... 47 4.3.1 HIGH COST OF TREATMENT ........... 47 4.3.2 REGULATORY CHALLENGES ............ 48 4.4 OPPORTUNITY ....... 49 4.4.1 GROWING DEMAND FOR MINIMALLY INVASIVE TREATMENTS ......... 49 5. MARKET FACTOR ANALYSIS ............ 50 5.1 VALUE CHAIN ANALYSIS ..... 50 5.1.1 R&D ......... 51 5.1.2 MANUFACTURING .... 51 5.1.3 DISTRIBUTION AND SALES ............ 51 5.1.4 POST-SALES MONITORING ... 51 5.2 PORTER'S FIVE FORCES MODEL ... 52 5.2.1 THREAT OF NEW ENTRANTS ........... 52 5.2.2 BARGAINING POWER OF SUPPLIERS ........... 53 5.2.3 THREAT OF SUBSTITUTES .... 53 5.2.4 BARGAINING POWER OF BUYERS .... 53 5.2.5 INTENSITY OF RIVALRY ........ 53 6 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE......... 55 6.1 OVERVIEW .... 55 6.2 HYALURONIC ACID INJECTION .... 58 6.3 COLLAGEN INJECTION ........... 58 6.4 COMBINATION OF HYALURONIC ACID AND COLLAGEN ....... 59 7. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION ... 60 7.1 OVERVIEW .... 60 7.2 KNEE OSTEOARTHRITIS ........ 62 7.3 JOINT PAIN ... 63 7.4 VETERINARY APPLICATIONS ....... 63 7.5 POST-OPERATIVE RECOVERY ....... 64 7.6 OTHERS .......... 64 8. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL ... 65 8.1 OVERVIEW .... 65 8.2 HOSPITAL PHARMACIES ....... 67 8.3 RETAIL PHARMACIES ............ 68 8.4 ONLINE PHARMACIES ............ 68 9. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION ............ 69 9.1 OVERVIEW .... 69 9.2 NORTH AMERICA ........... 71 9.2.1 US............ 75 9.2.2 CANADA ............ 77 9.3 EUROPE .......... 79 9.3.1 GERMANY .......... 83 9.3.2 UK ........... 85 9.3.3 FRANCE ... 87 9.3.4 RUSSIA .... 89 9.3.5 SPAIN ...... 91 9.3.6 ITALY ....... 93 9.3.7 REST OF EUROPE .......... 95 9.4 ASIA PACIFIC ......... 97 9.4.1 CHINA ...... 101 9.4.2 INDIA ....... 103 9.4.3 JAPAN ..... 105 9.4.4 SOUTH KOREA .... 107 9.4.5 MALAYSIA ......... 109 9.4.6 THAILAND .......... 111 9.4.7 INDONESIA ......... 113 9.4.8 REST OF ASIA PACIFIC............ 115 9.5 LATIN AMERICA ... 117 9.5.1 BRAZIL ..... 121 9.5.2 MEXICO ... 123 9.5.3 ARGENTINA ....... 125 9.5.4 REST OF LATIN AMERICA ........ 127 9.6 MIDDLE EAST AND AFRICA ............ 129 9.6.1 GCC COUNTRIES........... 134 9.6.2 SOUTH AFRICA ... 136 9.6.3 REST OF MEA ..... 138 10. COMPETITIVE LANDSCAPE .... 141 10.1 INTRODUCTION ..... 141 10.2 MARKET SHARE ANALYSIS, 2024 ......... 141 10.3 COMPETITOR DASHBOARD... 142 10.4 PUBLIC PLAYERS STOCK SUMMARY ... 143 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ........ 144 10.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ............ 145 10.1.1 PRODUCT LAUNCH/APPROVAL ......... 145 11. COMPANY PROFILES .... 146 11.1 SEIKAGAKU CORPORATION ........... 146 11.1.1 COMPANY OVERVIEW ... 146 11.1.2 FINANCIAL OVERVIEW ............ 147 11.1.3 PRODUCTS OFFERED .... 148 11.1.4 KEY DEVELOPMENTS .... 148 11.1.5 SWOT ANALYSIS........... 149 11.1.6 KEY STRATEGIES .......... 149 11.2 BIOVENTUS, INC. ............ 150 11.2.1 COMPANY OVERVIEW ... 150 11.2.2 FINANCIAL OVERVIEW ............ 151 11.2.3 PRODUCTS OFFERED .... 152 11.2.4 KEY DEVELOPMENTS .... 152 11.2.5 SWOT ANALYSIS .......... 153 11.2.6 KEY STRATEGIES .......... 153 11.3 ANIKA THERAPEUTICS, INC .......... 154 11.3.1 COMPANY OVERVIEW ... 154 11.3.2 FINANCIAL OVERVIEW ............ 155 11.3.3 PRODUCTS OFFERED .... 155 11.3.4 KEY DEVELOPMENTS .... 156 11.3.5 SWOT ANALYSIS .......... 156 11.3.6 KEY STRATEGIES .......... 156 11.4 ZIMMER BIOMET ............ 157 11.4.1 COMPANY OVERVIEW ... 157 11.4.2 FINANCIAL OVERVIEW ............ 158 11.4.3 PRODUCT OFFERED ...... 158 11.4.4 KEY DEVELOPMENTS .... 158 11.4.5 KEY STRATEGIES .......... 159 11.5 SANOFI ........... 160 11.5.1 COMPANY OVERVIEW ... 160 11.5.2 FINANCIAL OVERVIEW ............ 161 11.5.3 PRODUCTS OFFERED .... 161 11.5.4 KEY DEVELOPMENTS .... 162 11.5.5 KEY STRATEGIES .......... 162 11.6 TEVA PHARMACEUTICAL INDUSTRIES LTD. ........ 163 11.6.1 COMPANY OVERVIEW ... 163 11.6.2 FINANCIAL OVERVIEW ............ 164 11.6.3 PRODUCTS OFFERED .... 165 11.6.4 KEY DEVELOPMENTS .... 165 11.6.5 KEY STRATEGIES .......... 165 11.7 FERRING B.V. .......... 166 11.7.1 COMPANY OVERVIEW ... 166 11.7.2 FINANCIAL OVERVIEW ............ 166 11.7.3 PRODUCTS OFFERED .... 167 11.7.4 KEY DEVELOPMENTS .... 167 11.7.5 SWOT ANALYSIS .......... 167 11.7.6 KEY STRATEGIES .......... 168 11.8 DR. REDDY’S LABORATORIES LTD. ......... 169 11.8.1 COMPANY OVERVIEW ... 169 11.8.2 FINANCIAL OVERVIEW ............ 170 11.8.3 PRODUCT OFFERED ...... 170 11.8.4 KEY DEVELOPMENTS .... 171 11.8.5 KEY STRATEGIES .......... 171 11.9 FIDIA FARMACEUTICI S.P.A ........... 172 11.9.1 COMPANY OVERVIEW ... 172 11.9.2 FINANCIAL OVERVIEW ............ 172 11.9.3 PRODUCTS OFFERED .... 173 11.9.4 KEY DEVELOPMENTS .... 173 11.9.5 KEY STRATEGIES .......... 173 11.10 SEMICAL BIOSURGERY .......... 174 11.10.1 COMPANY OVERVIEW ... 174 11.10.2 FINANCIAL OVERVIEW ............ 174 11.10.3 PRODUCTS OFFERED .... 174 11.10.4 KEY DEVELOPMENTS .... 174 11.10.5 KEY STRATEGIES .......... 175 11.11 AVANOS MEDICAL, INC. ......... 176 11.11.1 COMPANY OVERVIEW ... 176 11.11.2 FINANCIAL OVERVIEW ............ 177 11.11.3 PRODUCTS OFFERED .... 177 11.11.4 KEY DEVELOPMENTS .... 177 11.11.5 KEY STRATEGIES .......... 178 11.12 MAXIGEN BIOTECH INC. (MBI) ...... 179 11.12.1 COMPANY OVERVIEW ... 179 11.12.2 FINANCIAL OVERVIEW ............ 180 11.12.3 PRODUCTS OFFERED .... 180 11.12.4 KEY DEVELOPMENTS .... 181 11.12.5 SWOT ANALYSIS .......... 181 11.12.6 KEY STRATEGIES .......... 181 12. DATA CITATIONS ........... 182
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 41 TABLE 2 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 56 TABLE 3 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 57 TABLE 4 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY REGION, 2019–2035 (USD MILLION) TABLE 5 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR COLLAGEN INJECTION, BY REGION, 2019–2035 (USD MILLION) 58 TABLE 6 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR COMBINATION OF HYALURONIC ACID AND COLLAGEN, BY REGION, 2019–2035 (USD MILLION) 59 TABLE 7 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 8 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR KNEE OSTEOARTHRITIS, BY REGION, 2019–2035 (USD MILLION) 62 TABLE 9 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR JOINT PAIN, BY REGION, 2019–2035 (USD MILLION) 63 TABLE 10 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR VETERINARY APPLICATIONS, BY REGION, 2019–2035 (USD MILLION) 63 TABLE 11 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR POST-OPERATIVE RECOVERY, BY REGION, 2019–2035 (USD MILLION) 64 TABLE 12 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD MILLION) 64 TABLE 13 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 66 TABLE 14 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2035 (USD MILLION) 67 TABLE 15 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019-2035 (USD MILLION) 68 TABLE 16 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019-2035 (USD MILLION) 68 TABLE 17 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION, 2019–2035 (USD MILLION) 70 TABLE 18 NORTH AMERICA COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 72 TABLE 19 NORTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 73 TABLE 20 NORTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 74 TABLE 21 NORTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 74 TABLE 22 NORTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) 75 TABLE 23 US: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 24 US: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 75 TABLE 25 US: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 76 TABLE 26 US: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 76 TABLE 27 CANADA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 77 TABLE 28 CANADA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 77 TABLE 29 CANADA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 30 CANADA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 78 TABLE 31 EUROPE COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) TABLE 32 EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 81 TABLE 33 EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 82 TABLE 34 EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 35 EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 83 TABLE 36 GERMANY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 83 TABLE 37 GERMANY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 83 TABLE 38 GERMANY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 84 TABLE 39 GERMANY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 84 TABLE 40 UK: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 41 UK: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 85 TABLE 42 UK: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 86 TABLE 43 UK: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 86 TABLE 44 FRANCE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 87 TABLE 45 FRANCE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 87 TABLE 46 FRANCE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 47 FRANCE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 88 TABLE 48 RUSSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 49 RUSSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 89 TABLE 50 RUSSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 51 RUSSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 90 TABLE 52 SPAIN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 53 SPAIN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 91 TABLE 54 SPAIN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 55 SPAIN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 92 TABLE 56 ITALY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 57 ITALY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 93 TABLE 58 ITALY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 59 ITALY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 94 TABLE 60 REST OF EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 95 TABLE 61 REST OF EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 95 TABLE 62 REST OF EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 96 TABLE 63 REST OF EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) 96 TABLE 64 ASIA PACIFIC COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION, 2019–2035 (USD MILLION) TABLE 65 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 99 TABLE 66 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 100 TABLE 67 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 100 TABLE 68 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 101 TABLE 69 CHINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 70 CHINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 101 TABLE 71 CHINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 72 CHINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 102 TABLE 73 INDIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 74 INDIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 103 TABLE 75 INDIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 76 INDIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) TABLE 77 JAPAN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 78 JAPAN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 105 TABLE 79 JAPAN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 80 JAPAN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 106 TABLE 81 SOUTH KOREA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 107 TABLE 82 SOUTH KOREA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 107 TABLE 83 SOUTH KOREA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 108 TABLE 84 SOUTH KOREA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) 108 TABLE 85 MALAYSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 109 TABLE 86 MALAYSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 109 TABLE 87 MALAYSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 110 TABLE 88 MALAYSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 110 TABLE 89 THAILAND: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 111 TABLE 90 THAILAND: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 111 TABLE 91 THAILAND: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 112 TABLE 92 THAILAND: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 112 TABLE 93 INDONESIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 113 TABLE 94 INDONESIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 113 TABLE 95 INDONESIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 114 TABLE 96 INDONESIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 114 TABLE 97 REST OF ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 115 TABLE 98 REST OF ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) 115 TABLE 99 REST OF ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 116 TABLE 100 REST OF ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) 116 TABLE 101 SOUTH AMERICA COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION, 2019–2035 (USD MILLION) 118 TABLE 102 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 103 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) TABLE 104 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 105 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) TABLE 106 BRAZIL: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 107 BRAZIL: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) TABLE 108 BRAZIL: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 109 BRAZIL: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) TABLE 110 MEXICO: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 111 MEXICO: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) TABLE 112 MEXICO: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 113 MEXICO: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) TABLE 114 ARGENTINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 115 ARGENTINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) TABLE 116 ARGENTINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 117 ARGENTINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) TABLE 118 REST OF LATIN AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) TABLE 119 REST OF LATIN AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) TABLE 120 REST OF LATIN AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) TABLE 121 REST OF LATIN AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) TABLE 122 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) TABLE 123 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) TABLE 124 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) TABLE 125 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) TABLE 126 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) TABLE 127 GCC COUNTRIES: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 128 GCC COUNTRIES: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) TABLE 129 GCC COUNTRIES: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 130 GCC COUNTRIES: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) TABLE 131 SOUTH AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 132 SOUTH AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) TABLE 133 SOUTH AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 134 SOUTH AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) TABLE 135 REST OF MEA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) TABLE 136 REST OF MEA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019–2035 (USD MILLION) TABLE 137 REST OF MEA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) TABLE 138 REST OF MEA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION) TABLE 139 PUBLIC PLAYERS STOCK SUMMARY TABLE 140 PRODUCT LAUNCH/APPROVAL TABLE 141 SEIKAGAKU CORPORATION.: PRODUCTS OFFERED TABLE 142 SEIKAGAKU CORPORATION: KEY DEVELOPMENTS TABLE 143 BIOVENTUS, INC.: PRODUCTS OFFERED TABLE 144 BIOVENTUS, INC.: KEY DEVELOPMENTS TABLE 145 ANIKA THERAPEUTICS, INC: PRODUCTS OFFERED TABLE 146 ZIMMER BIOMET: PRODUCTS OFFERED TABLE 147 SANOFI: PRODUCTS OFFERED TABLE 148 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED TABLE 149 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY DEVELOPMENTS TABLE 150 FERRING B.V.: PRODUCT OFFERED TABLE 151 DR. REDDY'S LABORATORIES LTD.: PRODUCTS OFFERED TABLE 152 FIDIA FARMACEUTICI S.P.A.: PRODUCT OFFERED TABLE 153 SEMICAL BIOSURGERY: PRODUCT OFFERED TABLE 154 AVANOS MEDICAL, INC.: PRODUCT OFFERED TABLE 155 MAXIGEN BIOTECH INC.(MBI): PRODUCT OFFERED TABLE 156 MAXIGEN BIOTECH INC.(MBI): KEY DEVELOPMENTS LIST OF FIGURES FIGURE 1 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2024 FIGURE 2 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET ANALYSIS, BY PRODUCT TYPE, 2024 FIGURE 3 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS ANALYSIS, BY APPLICATION, 2024 FIGURE 4 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS ANALYSIS, BY DISTRIBUTION CHANNEL, 2024 FIGURE 5 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET ANALYSIS, BY REGION, 2024 FIGURE 1 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET: STRUCTURE FIGURE 2 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2035) FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2035) FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2035) FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET FIGURE 7 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2024 (USD MILLION) 55 FIGURE 8 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2024 & 2035 (USD MILLION) FIGURE 9 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE (%), BY PRODUCT TYPE, 2024 FIGURE 10 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2024 (USD MILLION) 60 FIGURE 11 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) FIGURE 12 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE (%), BY APPLICATION, 2024 FIGURE 13 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2024 (USD MILLION) FIGURE 14 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2024 & 2035 (USD MILLION) FIGURE 15 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2024 FIGURE 16 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY REGION, 2024 & 2035 (USD MILLION) FIGURE 17 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY REGION, 2024 (%) FIGURE 18 NORTH AMERICA MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2035 (USD MILLION) FIGURE 19 NORTH AMERICA COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) FIGURE 20 NORTH AMERICA COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%) 73 FIGURE 21 EUROPE MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2035 (USD MILLION) FIGURE 22 EUROPE COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) FIGURE 23 EUROPE COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%) FIGURE 24 ASIA-PACIFIC MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2032 (USD MILLION) FIGURE 25 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) FIGURE 26 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%) FIGURE 27 LATIN AMERICA MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2032 (USD MILLION) FIGURE 28 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) FIGURE 29 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%) 119 FIGURE 30 MIDDLE EAST AND AFRICA MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2032 (USD MILLION) FIGURE 31 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) FIGURE 32 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%) FIGURE 33 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 FIGURE 34 COMPETITOR DASHBOARD: GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET FIGURE 35 SEIKAGAKU CORPORATION.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 36 SEIKAGAKU CORPORATION.: SWOT ANALYSIS FIGURE 37 BIOVENTUS, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 38 BIOVENTUS, INC: SWOT ANALYSIS FIGURE 39 ANIKA THERAPEUTICS, INC: FINANCIAL OVERVIEW SNAPSHOT FIGURE 40 ANIKA THERAPEUTICS INC.: SWOT ANALYSIS FIGURE 41 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT FIGURE 42 SANOFI: FINANCIAL OVERVIEW SNAPSHOT FIGURE 43 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 44 FERRING B.V.: SWOT ANALYSIS FIGURE 45 DR. REDDY'S LABORATORIES LTD.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 46 AVANOS MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 47 MAXIGEN BIOTECH INC.(MBI): FINANCIAL OVERVIEW SNAPSHOT FIGURE 48 MAXIGEN BIOTECH INC.(MBI): SWOT ANALYSIS

提及公司

Seikagaku CorporationBioventusInc.Anika TherapeuticsInc.Zimmer BiometSanofiFidia Farmaceutici S.p.A.Teva Pharmaceutical Industries Ltd.Ferring B.V.Dr. Reddy's Laboratories Ltd.Semical BiosurgeryAvanos MedicalInc.Maxigen Biotech Inc. (MBI).

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們